Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 15/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.32 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17870719 | 0.91 | GNRHR (0.38) | GNRHRCYP3A4BRD4PDK2TRPV4 | |
| SCHEMBL30178637 | 0.91 | GNRHR (0.38) | GNRHRCYP3A4BRD4PDK2TRPV4 | |
| SCHEMBL30178380 | 0.87 | GNRHR (0.36) | GNRHRCYP3A4BRD4PDK2P2RX3 | |
| SCHEMBL19874027 | 0.87 | GNRHR (0.36) | GNRHRCYP3A4BRD4PDK2P2RX3 | |
| SCHEMBL28660744 | 0.84 | GNRHR (0.40) | GNRHRCYP3A4 | |
| SCHEMBL19873999 | 0.82 | GNRHR (0.35) | GNRHRCYP3A4BRD4PDK2TRPV4 | |
| SCHEMBL30178426 | 0.82 | GNRHR (0.35) | GNRHRCYP3A4BRD4PDK2TRPV4 | |
| SCHEMBL28638881 | 0.81 | GNRHR (0.40) | GNRHRCYP3A4PDCD1CD274 | |
| SCHEMBL28651462 | 0.80 | GNRHR (0.41) | GNRHRCYP3A4PDCD1CD274 | |
| SCHEMBL28638656 | 0.79 | GNRHR (0.41) | GNRHRCYP3A4PDCD1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107428744-B | Novel heterocyclic compounds and their use in medicine and cosmetics | 盖尔德马研究及发展公司 | 2021-09-24 | — | — | CN | disclosed |